Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 40.9B | 38.0B | 36.8B | 35.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 17.1B | 16.7B | 16.5B | 16.0B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 10.1B | 8.3B | 7.0B | 6.9B |
| Tax provision | 2.6B | 2.1B | 1.3B | 1.7B |
| Net income | 7.4B | 6.2B | 5.7B | 5.2B |
| Basic EPS | — | 0.2 | 0.2 | 0.2 |
| Diluted EPS | — | 0.2 | 0.2 | 0.2 |
| Basic average shares | — | 31.0B | 31.5B | 30.4B |
| Diluted average shares | — | 31.0B | 31.5B | 30.4B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -500K | -600K | — | — |
| Preferred stock dividends | — | — | — | — |